| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.32 | 5e-11 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |